NervGen Pharma's total assets for Q4 2024 were C$19.49M, a decrease of -13.23% from the previous quarter. TSE:NGEN total liabilities were C$16.91M for the fiscal quarter, a 27.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.